Elizabeth Frank
Dana-Farber Cancer Institute – Patient Advocate
Translational Breast Cancer Research Consortium – Patient Advocate
Cancer Therapy Evaluation Program (CTEP), National Cancer Institute (NCI) – Patient Advocate
Elizabeth Frank, MA, is a long-term breast cancer survivor with a professional background in market research and program evaluation. She has been involved in numerous PCORI proposals and funded projects. Frank has been a patient stakeholder as well as the lead patient stakeholder on a several different projects. She is deeply committed to finding meaningful ways of engaging patient stakeholders in clinical, translational, and outcomes research. She is interested in getting involved in projects in which she can collaborate on projects/questions that have the potential to change practice and improve lives.
Involvement with PCORI
Research: Comparing Treatment Options for Women with Low-Risk Ductal Carcinoma In Situ (DCIS) (COMET) – Patient Advocate
Research: Kaiser Permanente & Strategic Partners Patient Outcomes Research To Advance Learning (PORTAL) Network – Patient Advocate
Research: Study of Radiation Fractionation on Outcomes After Breast REConstruction (FABREC) – Patient Advocate
Research: Improving Informed Consent for Palliative Chemotherapy – Patient Advocate
PCORI Merit Reviewer
PCORI Peer Reviewer